Query 032061
Match_columns 148
No_of_seqs 113 out of 1027
Neff 9.3
Searched_HMMs 46136
Date Fri Mar 29 09:04:49 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/032061.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/032061hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 cd02054 angiotensinogen Angiot 100.0 8.3E-30 1.8E-34 196.5 14.2 137 6-146 2-155 (372)
2 COG4826 Serine protease inhibi 100.0 9.9E-31 2.1E-35 191.8 7.1 141 4-147 36-182 (410)
3 cd02044 ov-serpin ovalbumin fa 100.0 1.8E-29 3.9E-34 194.6 12.6 135 8-146 3-142 (370)
4 cd02047 HCII Heparin cofactor 100.0 2.7E-29 5.7E-34 196.9 13.4 141 3-146 62-214 (436)
5 cd02049 bacterial_SERPIN SERin 100.0 1.7E-29 3.7E-34 194.4 11.7 136 7-146 2-142 (364)
6 cd02057 maspin_like Maspin (ma 100.0 1.3E-29 2.7E-34 195.6 10.4 136 7-146 2-142 (372)
7 cd02043 plant_SERPIN SERine Pr 100.0 3.5E-29 7.5E-34 193.7 11.5 138 9-146 2-144 (381)
8 cd02058 PAI-2 Plasminogen Acti 100.0 3.9E-29 8.3E-34 193.4 11.5 136 7-146 2-146 (380)
9 cd02059 ovalbumin_like The ova 100.0 7.2E-29 1.6E-33 192.4 13.0 136 7-146 2-159 (389)
10 cd02046 hsp47 Heat shock prote 100.0 7E-29 1.5E-33 191.1 12.8 138 6-146 3-146 (366)
11 cd02056 alpha-1-antitrypsin_li 100.0 4.2E-29 9.1E-34 192.0 10.6 134 9-146 1-142 (361)
12 cd02051 PAI-1_nexin-1 Plasmino 100.0 6.5E-29 1.4E-33 192.0 10.9 139 3-146 4-146 (377)
13 cd00172 SERPIN SERine Proteina 100.0 9E-29 1.9E-33 190.3 11.5 133 10-146 2-140 (364)
14 cd02045 antithrombin-III_like 100.0 7.1E-29 1.5E-33 192.0 10.5 142 3-146 2-153 (381)
15 PF00079 Serpin: Serpin (serin 100.0 2E-28 4.4E-33 188.4 13.0 137 8-147 1-143 (371)
16 cd02048 neuroserpin Neuroserpi 100.0 8.1E-29 1.8E-33 192.1 10.3 135 8-146 2-142 (388)
17 cd02052 PEDF Pigment epitheliu 100.0 1.4E-28 3E-33 189.9 9.8 138 2-146 11-153 (374)
18 KOG2392 Serpin [Defense mechan 99.9 3.5E-27 7.6E-32 182.2 13.5 140 4-147 5-152 (380)
19 cd02055 PZI Protein Z-dependen 99.9 7.5E-28 1.6E-32 185.3 9.2 133 6-146 2-145 (365)
20 smart00093 SERPIN SERine Prot 99.9 2.4E-27 5.2E-32 182.1 10.9 128 15-146 1-137 (359)
21 cd02053 alpha2AP Alpha2-antipl 99.9 1.6E-27 3.5E-32 182.7 8.6 130 7-146 2-136 (351)
22 cd02050 C1_inh C1 inhibitor (C 99.9 4.8E-27 1E-31 180.1 7.2 128 9-146 1-132 (352)
23 PHA02948 serine protease inhib 99.9 1.3E-24 2.8E-29 167.7 8.5 132 6-146 17-151 (373)
24 PHA02660 serpin-like protein; 99.9 1.2E-22 2.5E-27 156.4 5.8 115 5-146 10-129 (364)
25 PF04079 DUF387: Putative tran 77.5 13 0.00029 25.5 6.2 72 41-120 3-74 (159)
26 PTZ00100 DnaJ chaperone protei 77.1 17 0.00038 23.6 7.7 70 11-82 17-95 (116)
27 TIGR00281 segregation and cond 67.7 41 0.00089 23.8 7.6 75 43-123 8-83 (186)
28 COG1386 scpB Chromosome segreg 64.0 44 0.00095 23.6 6.4 69 43-119 15-83 (184)
29 PRK00135 scpB segregation and 63.7 50 0.0011 23.4 7.5 71 43-120 11-82 (188)
30 COG1510 Predicted transcriptio 56.4 26 0.00057 24.5 4.1 42 35-77 25-66 (177)
31 PF13766 ECH_C: 2-enoyl-CoA Hy 56.2 38 0.00082 21.9 4.8 37 6-51 25-61 (118)
32 PF01726 LexA_DNA_bind: LexA D 52.7 31 0.00068 19.8 3.6 27 51-77 25-51 (65)
33 PRK10046 dpiA two-component re 46.5 57 0.0012 23.1 4.9 41 33-74 159-199 (225)
34 PF14679 FANCI_HD1: FANCI heli 46.0 5.3 0.00012 24.6 -0.5 47 12-62 1-47 (87)
35 KOG1597 Transcription initiati 39.5 68 0.0015 24.5 4.4 47 33-80 240-288 (308)
36 PRK13870 transcriptional regul 33.7 76 0.0017 23.1 3.9 39 41-80 178-216 (234)
37 PF09186 DUF1949: Domain of un 31.9 61 0.0013 17.2 2.5 36 108-144 9-56 (56)
38 PF11124 Pho86: Inorganic phos 27.1 1.2E+02 0.0025 23.4 3.9 40 5-46 26-65 (304)
39 PF01851 PC_rep: Proteasome/cy 26.3 94 0.002 15.3 2.9 26 39-64 3-29 (35)
40 COG5567 Predicted small peripl 25.7 24 0.00052 19.7 0.1 24 29-52 2-25 (58)
41 PF00832 Ribosomal_L39: Riboso 25.7 37 0.0008 18.0 0.8 14 134-147 16-29 (43)
42 KOG0716 Molecular chaperone (D 25.6 1.5E+02 0.0032 22.5 4.1 38 49-86 25-65 (279)
43 PF00196 GerE: Bacterial regul 24.8 1.2E+02 0.0027 16.4 3.0 37 44-81 11-47 (58)
44 PF08672 APC2: Anaphase promot 23.5 1.2E+02 0.0025 17.2 2.7 23 38-60 17-41 (60)
45 PF12802 MarR_2: MarR family; 23.2 1.4E+02 0.003 16.1 4.5 33 41-74 10-43 (62)
46 PF00325 Crp: Bacterial regula 21.0 1.2E+02 0.0027 14.8 3.4 23 53-76 4-26 (32)
47 KOG1736 Glia maturation factor 20.2 44 0.00095 22.1 0.5 34 31-64 91-126 (143)
48 PRK10188 DNA-binding transcrip 20.1 2E+02 0.0043 21.0 4.0 37 44-81 187-223 (240)
49 KOG0002 60s ribosomal protein 20.0 48 0.001 17.8 0.5 14 134-147 21-34 (48)
No 1
>cd02054 angiotensinogen Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis. It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.
Probab=99.97 E-value=8.3e-30 Score=196.54 Aligned_cols=137 Identities=17% Similarity=0.143 Sum_probs=117.6
Q ss_pred hhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCCh------------HHHHHHH
Q 032061 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSD------------DQLNTFA 73 (148)
Q Consensus 6 ~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~------------~~~~~~~ 73 (148)
|+..+++||++||+.+... .+++|+|+||+||+.+|+|++.||+|+|++||.++|+++.. .+++..+
T Consensus 2 ~~~~~~~f~~~l~~~l~~~-~~~~N~v~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 80 (372)
T cd02054 2 LAMLVNVLGLRMYGMLSEL-WVHTNTLLSPTSVFGTLASLYLGASKKTADSLQALLGLPWKSKNSDCTSRVDGHKVLSTL 80 (372)
T ss_pred hHHHHHHHHHHHHHHHHhh-CCCCCEEEChHHHHHHHHHHHcCCCccHHHHHHHHhCCCcccccccccccccHHHHHHHH
Confidence 5678899999999999864 57889999999999999999999999999999999998732 2345566
Q ss_pred HHHHHHHhhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhcccc-ceEecCCCCccc----chhHHHhhcCCcc
Q 032061 74 SELVAVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAA-SNQVDFQTKVKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 74 ~~l~~~l~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~-~~~~df~~~~~~----N~wv~~~T~g~I~ 146 (148)
+.+...+.. ......+..+|++|++++++++++|++.++++|+++ ++.+||.++..+ |+||+++|+|+|+
T Consensus 81 ~~~~~~~~~---~~~~~~l~~a~~i~~~~~~~l~~~f~~~~~~~y~a~~~~~vdF~~~~~a~~~IN~WV~~~T~g~I~ 155 (372)
T cd02054 81 QAIQSLVDA---QGRQLLLSTVVWTFTAPGIHLSQPFVQGLADFSDASFPRSVDFTEPDVAEEKINNFVQATSDGKVK 155 (372)
T ss_pred HHHHHHHcC---CCCccEEEEEEEEEecCCCCccHHHHHHHHHHhCcccceeecCCChHHHHHHHHHHHHHHhcCchh
Confidence 666655542 234567999999999999999999999999999997 999999886654 9999999999997
No 2
>COG4826 Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones]
Probab=99.97 E-value=9.9e-31 Score=191.79 Aligned_cols=141 Identities=23% Similarity=0.376 Sum_probs=124.7
Q ss_pred HhhhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCCh-HHHHHHHHHHHHHHhh
Q 032061 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSD-DQLNTFASELVAVVFA 82 (148)
Q Consensus 4 ~~~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~~~~~~l~~~l~~ 82 (148)
-+.+.+++.||++||.++++++...+|++|||+||+.+|+|.|.||.|.|++||..++.++.. ..+....+.+...+.
T Consensus 36 y~ia~ANNaF~FdlyS~~~~~~~~~~Ni~fSPySV~~AmAmcY~GaeGsTkeqmsnvfyfp~n~~vl~~~~~~~nd~i~- 114 (410)
T COG4826 36 YDIAAANNAFAFDLYSELAKQEGEAENILFSPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPINKTVLKVREKSLNDKIN- 114 (410)
T ss_pred cchhhcccchhHHHHHHHHhhcccccceeeccHHHHHHHHHHhcccCcchHHHHHhheeccccchHhhhhHHhhccccc-
Confidence 457889999999999999986557899999999999999999999999999999999999954 345555666666665
Q ss_pred CCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc-----chhHHHhhcCCccC
Q 032061 83 DGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT-----LSWYTTVIHEGLKF 147 (148)
Q Consensus 83 ~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~-----N~wv~~~T~g~I~~ 147 (148)
.+..+++|..+|.+|+++++.+++.|+..++.+|++++..+||.+.+.+ |+||+++|+|||+.
T Consensus 115 --sp~~~y~le~AnalWvqedyplke~yv~n~r~yy~aevtnlDF~~~p~~s~dtINkWvEekT~gkIkd 182 (410)
T COG4826 115 --SPNDSYELETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVNKPDASRDTINKWVEEKTNGKIKD 182 (410)
T ss_pred --CCccchhhhhhhhHHHhcCCCCCHHHHHHHHhhhhcceeecccccCchHHHHHHHHHHHHhhcchHhh
Confidence 4667899999999999999999999999999999999999999876664 99999999999974
No 3
>cd02044 ov-serpin ovalbumin family of serpins (ov-serpins). Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia.
Probab=99.96 E-value=1.8e-29 Score=194.63 Aligned_cols=135 Identities=20% Similarity=0.285 Sum_probs=121.5
Q ss_pred hhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCCCCC
Q 032061 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVFADGSPS 87 (148)
Q Consensus 8 ~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~ 87 (148)
.++++|+++||+++... .+++|+|+||+||+.+|+|++.||+|.|++||.++|+++...+++..++.+.+.+.+ ..
T Consensus 3 ~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~---~~ 78 (370)
T cd02044 3 LANSAFAVDVFKELSKK-SALQNVFFSPIAIMSSLAMVYLGAKGSTANQIGKVLHFDNVKDVHSSFQTLLSDINK---LN 78 (370)
T ss_pred chhhHHHHHHHHHHhhc-CCCCcEEECHHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCHHHHHHHHHHHHHHHhc---CC
Confidence 56789999999999863 678999999999999999999999999999999999998666788899999888763 23
Q ss_pred CCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCc-cc----chhHHHhhcCCcc
Q 032061 88 GGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKV-KT----LSWYTTVIHEGLK 146 (148)
Q Consensus 88 ~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~-~~----N~wv~~~T~g~I~ 146 (148)
....+.++|++|++++++++++|.+.++++|++++..+||.+++ .+ |.||+++|+|+|+
T Consensus 79 ~~~~l~~a~~~~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~ 142 (370)
T cd02044 79 SFYSLKLVNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKDKAEETRGQINSWIKDQTKGKIE 142 (370)
T ss_pred CCceEeeeeehhhcCCCcccHHHHHHHHHhhccceEeccccCCHHHHHHHHHHHHHHhcCCchh
Confidence 45789999999999999999999999999999999999998753 22 9999999999996
No 4
>cd02047 HCII Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade. HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily.
Probab=99.96 E-value=2.7e-29 Score=196.92 Aligned_cols=141 Identities=21% Similarity=0.278 Sum_probs=123.9
Q ss_pred hHhhhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCC---------hHHHHHHH
Q 032061 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS---------DDQLNTFA 73 (148)
Q Consensus 3 ~~~~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~---------~~~~~~~~ 73 (148)
++++..++++||++||+.+....++++|+++||+||+.+|+|++.||+|.|++||.++|+++. ..+++..+
T Consensus 62 ~~~~~~~~~~Fa~~L~~~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~Lg~~~~~~~~~~~~~~~~~~~~ 141 (436)
T cd02047 62 IQRLNILNANFGFNLYRVLKDQVNTSDNILLAPVGISTAMGMISLGLKGQTQEQVLSTLGFKDFVNASSKYEITTVHNLF 141 (436)
T ss_pred hhHHHHHHhHHHHHHHHHHhhccCCCCcEEEChHHHHHHHHHHHhhcccHHHHHHHHHhcccccccccccccHHHHHHHH
Confidence 467888999999999999975324789999999999999999999999999999999999862 13578888
Q ss_pred HHHHHHHhhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc---chhHHHhhcCCcc
Q 032061 74 SELVAVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT---LSWYTTVIHEGLK 146 (148)
Q Consensus 74 ~~l~~~l~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~---N~wv~~~T~g~I~ 146 (148)
+.+.+.+.+ ...+..+.++|++|++++++++++|.+.++++|+++++.+||.++..+ |+||+++|+|+|+
T Consensus 142 ~~l~~~l~~---~~~~~~L~~an~l~v~~~~~l~~~F~~~~~~~y~a~v~~vdF~~~~~~~~IN~wV~~~T~g~I~ 214 (436)
T cd02047 142 RKLTHRLFR---RNFGYTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQIADFSDPAFITKTNNRIQKLTKGLIK 214 (436)
T ss_pred HHHHHHhhc---CCCCcEEeeeeehhhhCCCCccHHHHHHHHHHhcCceEEeCCCCHHHHHHHHHHHHHhcCCccc
Confidence 888887753 334678999999999999999999999999999999999999886544 9999999999997
No 5
>cd02049 bacterial_SERPIN SERine Proteinase INhibitors (serpins), prokaryotic subgroup. Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors.
Probab=99.96 E-value=1.7e-29 Score=194.35 Aligned_cols=136 Identities=24% Similarity=0.380 Sum_probs=120.9
Q ss_pred hhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCC--hHHHHHHHHHHHHHHhhCC
Q 032061 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS--DDQLNTFASELVAVVFADG 84 (148)
Q Consensus 7 ~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~--~~~~~~~~~~l~~~l~~~~ 84 (148)
..+.++||++||+++... .+++|+|+||+||+.+|+|++.||+|.|++||.++|+++. ..+++..++.+...+..
T Consensus 2 ~~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l~~-- 78 (364)
T cd02049 2 NDANTRFGFKLFSELNKE-DVEKNIFISPLSIALALSMTYNGADGTTRKEMLKALGLDNIDLEDLNSALATLMDQLNT-- 78 (364)
T ss_pred cchhhHHHHHHHHHHhhc-CCCCCEEECHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHhc--
Confidence 457899999999999864 6789999999999999999999999999999999999975 34688888888887763
Q ss_pred CCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc---chhHHHhhcCCcc
Q 032061 85 SPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT---LSWYTTVIHEGLK 146 (148)
Q Consensus 85 ~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~---N~wv~~~T~g~I~ 146 (148)
...+..+.++|++|++++++++++|.+.++++|++++..+||.++..+ |+||+++|+|+|+
T Consensus 79 -~~~~~~l~~an~i~~~~~~~~~~~f~~~~~~~~~~~v~~~dF~~~~a~~~IN~wv~~~T~g~I~ 142 (364)
T cd02049 79 -HDKTVELIIANSIWIEPGFTLKPDFLQTIKDYYQAYVLELDFQSPAAAEEINRWVKEKTKGKID 142 (364)
T ss_pred -CCCCcEEEeehhhHhhCCCCccHHHHHHHHHhhcccceeeCCCCHHHHHHHHHHHHHhhcChHH
Confidence 234578999999999999999999999999999999999999886433 9999999999986
No 6
>cd02057 maspin_like Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages. Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.
Probab=99.96 E-value=1.3e-29 Score=195.60 Aligned_cols=136 Identities=23% Similarity=0.277 Sum_probs=119.7
Q ss_pred hhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCCCC
Q 032061 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVFADGSP 86 (148)
Q Consensus 7 ~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~ 86 (148)
..++++||++||+.+... .+++|+|+||+||+.+|+|++.||+|.|++||.++|+++...+++..++.+...+.+ .
T Consensus 2 ~~~~~~F~~~l~~~~~~~-~~~~Nvv~SP~si~~aL~ml~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~---~ 77 (372)
T cd02057 2 QLANTAFAVDLFKKLCEK-EPTGNVVFSPICLSTSLALAQVGAKGDTANEIGKVLHFENVKDVPFGFQTVTSDVSK---L 77 (372)
T ss_pred cchhhHHHHHHHHHHhcc-CCCCcEEECHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCChhHHHHHHHHHHHHHhc---C
Confidence 457899999999999863 678999999999999999999999999999999999998666677778888777653 2
Q ss_pred CCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCc-cc----chhHHHhhcCCcc
Q 032061 87 SGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKV-KT----LSWYTTVIHEGLK 146 (148)
Q Consensus 87 ~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~-~~----N~wv~~~T~g~I~ 146 (148)
.....+.++|++|++++++++++|.+.++++|++++..+||.+.+ .+ |+||+++|+|+|+
T Consensus 78 ~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~ 142 (372)
T cd02057 78 SSFYSLKLIKRLYVDKSLNLSTDFINSTKRPYPKELETVDFKDKLEETRGQINNSIKELTDGHFE 142 (372)
T ss_pred CccchhHhhhhhhhhCCCCccHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhccChhh
Confidence 335679999999999999999999999999999999999998653 33 9999999999997
No 7
>cd02043 plant_SERPIN SERine Proteinase INhibitors (serpins), plant specific subgroup. It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.
Probab=99.96 E-value=3.5e-29 Score=193.70 Aligned_cols=138 Identities=54% Similarity=0.803 Sum_probs=119.0
Q ss_pred hhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCCCCCC
Q 032061 9 NQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVFADGSPSG 88 (148)
Q Consensus 9 ~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~~ 88 (148)
..++||++||+.+....++++|+|+||+||+.+|+||+.||+|.|++||.++|+++...+++..++.+.+.+........
T Consensus 2 ~~~~~~~~l~~~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~l~~~~~~~~~~~~ 81 (381)
T cd02043 2 NQCLVAMRLSGHVAAAAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPSTDELHAVAASIVDLVLADASASG 81 (381)
T ss_pred chHHHHHHHHHHHhccCCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCChHHHHHHHHHHHHHHhhhcccCC
Confidence 46899999999998742378999999999999999999999999999999999998666778888888777643211233
Q ss_pred CCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCC-ccc----chhHHHhhcCCcc
Q 032061 89 GPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTK-VKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 89 ~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~-~~~----N~wv~~~T~g~I~ 146 (148)
...+.++|+||++++++++++|.+.++++|+++++.+||.+. ..+ |+||+++|+|+|+
T Consensus 82 ~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~ 144 (381)
T cd02043 82 GPRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDFRTKAEEVRREVNSWVEKATNGLIK 144 (381)
T ss_pred CcEEehhhhHHHhCCCCcCHHHHHHHHhhhhccceeecCCCCHHHHHHHHHHHHHHHhcChHH
Confidence 568999999999999999999999999999999999999864 333 9999999999986
No 8
>cd02058 PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2). PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration.
Probab=99.96 E-value=3.9e-29 Score=193.38 Aligned_cols=136 Identities=25% Similarity=0.373 Sum_probs=120.7
Q ss_pred hhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCCh----HHHHHHHHHHHHHHhh
Q 032061 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSD----DQLNTFASELVAVVFA 82 (148)
Q Consensus 7 ~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~~~~~~l~~~l~~ 82 (148)
..+.++|+++||+++... .+++|+|+||+||+.+|+||+.||+|.|++||.++|+++.. .+++..++.+.+.+.+
T Consensus 2 ~~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~~~~ 80 (380)
T cd02058 2 SAANTSFALNLFKKLAES-SPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVGGNSEDIHSGFQSLLSEINK 80 (380)
T ss_pred chhhhHHHHHHHHHHhhc-CCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCcCccccchHHHHHHHHHHHHHHhC
Confidence 457899999999999863 67899999999999999999999999999999999999753 5688888888888763
Q ss_pred CCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCc-cc----chhHHHhhcCCcc
Q 032061 83 DGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKV-KT----LSWYTTVIHEGLK 146 (148)
Q Consensus 83 ~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~-~~----N~wv~~~T~g~I~ 146 (148)
+.....+.++|+||++++++++++|.+.++++|++++..+||.+++ .+ |+||+++|+|+|+
T Consensus 81 ---~~~~~~l~~~n~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~ 146 (380)
T cd02058 81 ---PGTNYLLKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAVDFVEAAEQARKEINSWVERQTEGKIQ 146 (380)
T ss_pred ---CCCccEeehhhhhhhcCCCcHhHHHHHHHHhhhcCceEEecCCCCHHHHHHHHHHHHHHhcccchh
Confidence 3345689999999999999999999999999999999999998653 33 9999999999997
No 9
>cd02059 ovalbumin_like The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily. Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin.
Probab=99.96 E-value=7.2e-29 Score=192.40 Aligned_cols=136 Identities=24% Similarity=0.411 Sum_probs=120.1
Q ss_pred hhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCC-----------------hHHH
Q 032061 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS-----------------DDQL 69 (148)
Q Consensus 7 ~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~-----------------~~~~ 69 (148)
..+.++|+++||+.+... .+++|+|+||+||+.+|+|++.||+|.|+.||.++|+++. ..++
T Consensus 2 ~~~~~~Fa~~l~~~~~~~-~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (389)
T cd02059 2 SAANTEFCFDLFKELKKN-HKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGSSKPAASAQCNQSGGV 80 (389)
T ss_pred cchhhHHHHHHHHHHhhc-CCCCCEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCccccccccccccccccccHHHH
Confidence 457899999999999863 5789999999999999999999999999999999999863 1357
Q ss_pred HHHHHHHHHHHhhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCcc-c----chhHHHhhcCC
Q 032061 70 NTFASELVAVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVK-T----LSWYTTVIHEG 144 (148)
Q Consensus 70 ~~~~~~l~~~l~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~-~----N~wv~~~T~g~ 144 (148)
+..++.+...+.+ +.....+.++|+||++++++++++|.+.++++|+++++.+||.++.. + |+||+++|+|+
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~ 157 (389)
T cd02059 81 HSQFKDLLSQINK---PNDDYELSIANRLYGEKTYPFHQEYLDCVEKLYRAKLEPVDFQNAAEASRKKINSWVESQTNGK 157 (389)
T ss_pred HHHHHHHHHHHcC---CCCCcEEEEeeehhhhCCCCccHHHHHHHHHHhcCeeEEEcCCCCHHHHHHHHHHHHHHhccch
Confidence 7888888888763 34557899999999999999999999999999999999999987643 2 99999999999
Q ss_pred cc
Q 032061 145 LK 146 (148)
Q Consensus 145 I~ 146 (148)
|+
T Consensus 158 I~ 159 (389)
T cd02059 158 IK 159 (389)
T ss_pred hh
Confidence 97
No 10
>cd02046 hsp47 Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen. It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H.
Probab=99.96 E-value=7e-29 Score=191.08 Aligned_cols=138 Identities=22% Similarity=0.311 Sum_probs=121.2
Q ss_pred hhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCC--hHHHHHHHHHHHHHHhhC
Q 032061 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS--DDQLNTFASELVAVVFAD 83 (148)
Q Consensus 6 ~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~--~~~~~~~~~~l~~~l~~~ 83 (148)
+....++||++||+++... .+++|+|+||+||+.+|+|++.||+|.|++||.++|+++. ..+++..++++...+..
T Consensus 3 ~~~~~~~f~~~l~~~~~~~-~~~~N~v~SP~si~~aLa~l~~Ga~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l~~- 80 (366)
T cd02046 3 LADRSAGLAFNLYHAMAKD-KGVENILLSPVVVASSLGLVSMGGKASTASQAKAVLSADKLKDEHVHTGLSELLNEVSN- 80 (366)
T ss_pred hhhhhhHHHHHHHHHhhcc-CCCCeEEEChHHHHHHHHHHHhhcCccHHHHHHHHhCCCCCCcHHHHHHHHHHHHHhhc-
Confidence 4567889999999999863 5789999999999999999999999999999999999863 34678888888877753
Q ss_pred CCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc----chhHHHhhcCCcc
Q 032061 84 GSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 84 ~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~----N~wv~~~T~g~I~ 146 (148)
....+..+.++|++|++++++++++|.+.++++|++++..+||.++..+ |+||+++|+|+|+
T Consensus 81 -~~~~~~~l~~an~~~~~~~~~l~~~F~~~~~~~y~~~~~~vdF~~~~~a~~~IN~wv~~~T~g~I~ 146 (366)
T cd02046 81 -STARNVTWKIGNRLYGPSSVSFADDFVKNSKKHYNYEHSKINFRDKRSALNSINEWAAQTTDGKLP 146 (366)
T ss_pred -CCCCCcEEEEeeehhhcCCCChhHHHHHHHHHHhcCeeEEecCCChHHHHHHHHHHHHHhcCCchh
Confidence 1224578999999999999999999999999999999999999887654 9999999999997
No 11
>cd02056 alpha-1-antitrypsin_like alpha-1-antitrypsin_like. This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia.
Probab=99.96 E-value=4.2e-29 Score=192.01 Aligned_cols=134 Identities=25% Similarity=0.425 Sum_probs=119.4
Q ss_pred hhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCC----hHHHHHHHHHHHHHHhhCC
Q 032061 9 NQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS----DDQLNTFASELVAVVFADG 84 (148)
Q Consensus 9 ~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~----~~~~~~~~~~l~~~l~~~~ 84 (148)
++++|+++||+.+... .+++|+|+||+||+.+|+|++.||+|.|++||.++|+++. ..+++..++.++..+..
T Consensus 1 ~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~~-- 77 (361)
T cd02056 1 ANADFAFRLYRQLASE-SPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGFNLTEISEEEIHQGFQHLLHLLNQ-- 77 (361)
T ss_pred CccHHHHHHHHHHhhc-CCCCcEEEChHHHHHHHHHHHCccchhHHHHHHHHhcCCccCCCHHHHHHHHHHHHHHHcC--
Confidence 3579999999999763 5789999999999999999999999999999999999863 24688889999888863
Q ss_pred CCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc----chhHHHhhcCCcc
Q 032061 85 SPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 85 ~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~----N~wv~~~T~g~I~ 146 (148)
...+..+.++|+||++++++++++|.+.++++|+++++.+||.++..+ |.||+++|+|+|+
T Consensus 78 -~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~~dF~~~~~~~~~IN~wv~~~T~g~I~ 142 (361)
T cd02056 78 -PDSGLQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFSTDFQDSAEAKKQINDYVEKKTHGKIV 142 (361)
T ss_pred -CCCcceEEeeeehhhhCCCChhHHHHHHHHHHhcCceEeeCCCChHHHHHHHHHHHHHHhhhhHH
Confidence 234578999999999999999999999999999999999999876554 9999999999996
No 12
>cd02051 PAI-1_nexin-1 Plasminogen activator inhibitor-1_like. Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.
Probab=99.96 E-value=6.5e-29 Score=191.97 Aligned_cols=139 Identities=18% Similarity=0.296 Sum_probs=122.9
Q ss_pred hHhhhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHhh
Q 032061 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVFA 82 (148)
Q Consensus 3 ~~~~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~ 82 (148)
...+..+.++||++||+++... .+++|+|+||+||+.+|+|++.||+|+|+.||.++|+++. .++...++.+.+.+..
T Consensus 4 ~~~~~~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~~L~~l~~GA~g~T~~el~~~L~~~~-~~~~~~~~~l~~~l~~ 81 (377)
T cd02051 4 PSSLEELGSDFGIQVFNQVAQA-RPQENVVVSPHGIASVLGMLQLGADGKTKKQLQTVMRYKI-NGVAKALKKLNKAIVS 81 (377)
T ss_pred hHHHHHHHhHHHHHHHHHHHhc-CCCCcEEECcHHHHHHHHHHHhhcCCcHHHHHHHHhCCCh-hHHHHHHHHHHHHHhc
Confidence 3567889999999999999863 6789999999999999999999999999999999999974 4577778888777753
Q ss_pred CCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc----chhHHHhhcCCcc
Q 032061 83 DGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 83 ~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~----N~wv~~~T~g~I~ 146 (148)
......+.++|++|++++++++++|.+.++++|++++..+||.++..+ |.||+++|+|+|+
T Consensus 82 ---~~~~~~l~~an~i~~~~~~~l~~~f~~~~~~~f~a~~~~vdF~~~~~a~~~IN~Wv~~~T~g~I~ 146 (377)
T cd02051 82 ---KKNKDIVTTANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFSDPETAAFSINDWVKNETKGMID 146 (377)
T ss_pred ---cCCccchHHHHHHHhcCCCchhHHHHHHHHHHhcCeeEEECCCCHHHHHHHHHHHHHHhcCCCcc
Confidence 233457899999999999999999999999999999999999876554 9999999999997
No 13
>cd00172 SERPIN SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia.
Probab=99.96 E-value=9e-29 Score=190.26 Aligned_cols=133 Identities=30% Similarity=0.459 Sum_probs=119.9
Q ss_pred hHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCC--hHHHHHHHHHHHHHHhhCCCCC
Q 032061 10 QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS--DDQLNTFASELVAVVFADGSPS 87 (148)
Q Consensus 10 ~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~--~~~~~~~~~~l~~~l~~~~~~~ 87 (148)
+++|+++||+++... .+++|+|+||+||+.+|+|++.||+|.|++||.++|+++. ..+++..++.+.+.+.. ..
T Consensus 2 ~~~Fa~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~l~~---~~ 77 (364)
T cd00172 2 NNDFALDLYKQLAKS-EPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPSLDDEDVHQAFKSLLSSLKD---SE 77 (364)
T ss_pred cchHHHHHHHHHhhc-CCCCCEEEcHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHhC---CC
Confidence 578999999999863 5789999999999999999999999999999999999983 56788999999988863 23
Q ss_pred CCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc----chhHHHhhcCCcc
Q 032061 88 GGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 88 ~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~----N~wv~~~T~g~I~ 146 (148)
....+.++|++|+++++.++++|.+.++++|++++..+||.++..+ |.||+++|+|+|+
T Consensus 78 ~~~~l~~an~~~~~~~~~~~~~f~~~~~~~~~~~~~~~dF~~~~~a~~~IN~wv~~~T~g~I~ 140 (364)
T cd00172 78 KGVELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVESVDFANPEAAAAQINNWVEEKTNGKIK 140 (364)
T ss_pred CCceeeeehhhhhhCCCchhHHHHHHHHHHhcCeeEEEcCCChHHHHHHHHHHHHhhhcccch
Confidence 3568999999999999999999999999999999999999886544 9999999999996
No 14
>cd02045 antithrombin-III_like Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation. It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily.
Probab=99.96 E-value=7.1e-29 Score=191.95 Aligned_cols=142 Identities=26% Similarity=0.427 Sum_probs=120.5
Q ss_pred hHhhhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCC-----hHHHHHHHHHHH
Q 032061 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS-----DDQLNTFASELV 77 (148)
Q Consensus 3 ~~~~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~-----~~~~~~~~~~l~ 77 (148)
+..+..+.++||++||+++.....+++|+|+||+||+.+|+|++.||.|.|++||.++|+++. ...++..++.+.
T Consensus 2 ~~~~~~~~~~Fa~~l~~~l~~~~~~~~Niv~SP~si~~aL~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~ 81 (381)
T cd02045 2 VWELSKANSRFALAFYKHLADSKSNDENIFLSPLSISTAFAMTKLGACNNTLEQLMEVFQFDTISEKTSDQVHFFFAKLN 81 (381)
T ss_pred cchhhhhhhHHHHHHHHHHhcccCCCCCEEECcHHHHHHHHHHhhhcCCcHHHHHHHHhCCCccccccHHHHHHHHHHHH
Confidence 345777899999999999975324689999999999999999999999999999999999863 245777788777
Q ss_pred HHHhhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCcc-c----chhHHHhhcCCcc
Q 032061 78 AVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVK-T----LSWYTTVIHEGLK 146 (148)
Q Consensus 78 ~~l~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~-~----N~wv~~~T~g~I~ 146 (148)
..+.. ....+..+.++|++|++++++++++|.+.++++|++++..+||.+++. + |+||+++|+|+|+
T Consensus 82 ~~~~~--~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~I~ 153 (381)
T cd02045 82 CRLYR--KANKSSELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFKEKPELSRITINEWIANKTENRIT 153 (381)
T ss_pred HHHhc--ccCCcchhhhhhhhhhcCCCchhHHHHHHHHHhhcCeeEEecCCCCHHHHHHHHHHHHHHHHhhHHH
Confidence 76632 123456799999999999999999999999999999999999976432 2 9999999999997
No 15
>PF00079 Serpin: Serpin (serine protease inhibitor); InterPro: IPR023796 Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively. In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties. Serpins (SERine Proteinase INhibitors) [, , ] belong to MEROPS inhibitor family I4, clan ID. Serpins are proteins that are primarily known as irreversible serine protease inhibitors active against S1 (IPR001254 from INTERPRO), S8 (IPR000209 from INTERPRO) and C14 (IPR002398 from INTERPRO) peptidases. There are both extra- and intra-cellular serpins, which are found in all groups of organisms with the notable exception of fungi [, ]. In contrast to "rigid" proteinase inhibitors, such as those of the Kunitz or Kazal families, the serpins are metastable proteins (active-state proteins) which interact with their substrate and irreversibly trap the acyl intermediate as a result of a major conformational change []; they are best described as suicide substrate inhibitors. The common structure of these proteins is a multi-domain fold containing a bundle of 8 or 9 alpha helices and a beta sandwich formed by 3 beta sheets. The reactive centre loop (RCL) is found in the C-terminal part of these proteins. Serpins and their homologues are a group of high molecular weight (40 to 50 kDa) structurally related proteins involved in a number of fundamental biological processes such as blood coagulation, complement activation, fibrinolysis, angiogenesis, inflammation, tumour suppression and hormone transport. All known serpins have been classified into 16 clades and 10 orphan sequences; the vertebrate serpins can be conveniently classified into six sub-groups []. In human plasma they represent approximately 2% of the total protein, of which 70% is alpha-1-antitrypsin. On the basis of strong sequence similarities, a number of proteins with no known inhibitory activity also belong to this family, these include: angiotensinogen, corticosteroid-binding globulin and thyroxin-binding globulin []. This entry represents the structural domain of serpins. It consists of a cluster of helices and a beta-sandwich.; PDB: 3PZF_A 3B9F_I 1MTP_A 1SNG_A 1ANT_I 2ZNH_B 1BR8_I 1SR5_A 1E03_L 1AZX_L ....
Probab=99.96 E-value=2e-28 Score=188.41 Aligned_cols=137 Identities=29% Similarity=0.495 Sum_probs=123.5
Q ss_pred hhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCC--ChHHHHHHHHHHHHHHhhCCC
Q 032061 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSK--SDDQLNTFASELVAVVFADGS 85 (148)
Q Consensus 8 ~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~--~~~~~~~~~~~l~~~l~~~~~ 85 (148)
.++++||++||+.+... .+++|+|+||+||+.+|+|++.||+|+|+.||.++|+++ ...+++..++.+.+.+.. .
T Consensus 1 ~a~~~f~~~L~~~~~~~-~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l~~--~ 77 (371)
T PF00079_consen 1 AANNQFALKLFKALSKS-NPDENFVFSPLSIYSALAMLYLGASGETRKELRKVLGLPGSDDEEIHEYFKKLLQSLNS--S 77 (371)
T ss_dssp HHHHHHHHHHHHHHHHH-STTSSEEE-HHHHHHHHHHHHHTSCHHHHHHHHHHTTCTTSTHHHHHHHHHHHHHHHHS--C
T ss_pred ChHHHHHHHHHHHHHhh-CCCCcEEEChHHHHHHHHHHHhhccCCHHHHHHHHhhhcccccccchhhhhhhhhhhhc--c
Confidence 36899999999999885 689999999999999999999999999999999999996 346789999999998874 2
Q ss_pred CCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc----chhHHHhhcCCccC
Q 032061 86 PSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT----LSWYTTVIHEGLKF 147 (148)
Q Consensus 86 ~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~----N~wv~~~T~g~I~~ 147 (148)
......+.++|.+|++++++++++|.+.++++|+++++.+||.++..+ |.||+++|+|+|+.
T Consensus 78 ~~~~~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~~~~IN~wv~~~T~g~I~~ 143 (371)
T PF00079_consen 78 PSDNPQLKLANKLFVDKNLPLKPEFKKTLKKYFNAEVESVDFSDPPQAAKEINKWVSEKTNGKIKN 143 (371)
T ss_dssp STSSSEEEEEEEEEEETTSEBEHHHHHHHHHHHSEEEEEEETTSHHHHHHHHHHHHHHHTTTSSST
T ss_pred ccccccceeeeeeecccccccccccchhhhhccccccccccccccchhhhhhcchhhhhccceeec
Confidence 356788999999999999999999999999999999999999998744 99999999999974
No 16
>cd02048 neuroserpin Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA). It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily.
Probab=99.96 E-value=8.1e-29 Score=192.05 Aligned_cols=135 Identities=21% Similarity=0.368 Sum_probs=117.6
Q ss_pred hhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCCh--HHHHHHHHHHHHHHhhCCC
Q 032061 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSD--DQLNTFASELVAVVFADGS 85 (148)
Q Consensus 8 ~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~--~~~~~~~~~l~~~l~~~~~ 85 (148)
++.++||++||+++... ++++|+|+||+||+.+|+||+.||+|.|++||.++|+++.. .+....++.+...+..
T Consensus 2 ~~~~~Fa~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~--- 77 (388)
T cd02048 2 EAIAELSVDLYNALRAS-KEDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGYDGLKNGEEFSFLKDLSSMITA--- 77 (388)
T ss_pred chhhHHHHHHHHHhhcc-CCCCcEEEChHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCCChHHHHHHHHHHHHHhcc---
Confidence 46789999999999763 67899999999999999999999999999999999999753 3445566777766642
Q ss_pred CCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc----chhHHHhhcCCcc
Q 032061 86 PSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 86 ~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~----N~wv~~~T~g~I~ 146 (148)
......+.++|++|++++++++++|.+.++++|+++++.+||.++..+ |.||+++|+|+|+
T Consensus 78 ~~~~~~l~~an~i~v~~~~~l~~~f~~~~~~~f~~~~~~vdF~~~~~~~~~IN~wv~~~T~g~I~ 142 (388)
T cd02048 78 KEKEYVFNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFSQVKAVAEHINKWVENHTNNKIK 142 (388)
T ss_pred CCCccchHHhhhhHhhcCCCccHHHHHHHHHHhcCeeEEECCCChHHHHHHHHHHHHHhccCchh
Confidence 234567999999999999999999999999999999999999987554 9999999999997
No 17
>cd02052 PEDF Pigment epithelium-derived factor (PEDF)_like. PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily.
Probab=99.95 E-value=1.4e-28 Score=189.87 Aligned_cols=138 Identities=20% Similarity=0.239 Sum_probs=121.7
Q ss_pred ChHhhhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCC--hHHHHHHHHHHHHH
Q 032061 2 DVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS--DDQLNTFASELVAV 79 (148)
Q Consensus 2 ~~~~~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~--~~~~~~~~~~l~~~ 79 (148)
+.+++..+.++||++||+.+... .+++|+++||+||+.+|+|++.||+|.|++||+++|+++. ..+++..++.+...
T Consensus 11 ~~~~l~~~~~~Fa~~l~~~l~~~-~~~~Nvv~SP~si~~~L~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~ 89 (374)
T cd02052 11 PRNKLAAAVSNFGYDLYRQQASR-DPTANVFLSPLSIATALSQLSLGAGERTESQIHRALYYDLLNDPELHDTYKDLLAS 89 (374)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcc-CCCCcEEEChHHHHHHHHHHHhccChHHHHHHHHHhCCCCCChHHHHHHHHHHHHH
Confidence 46788999999999999999864 6789999999999999999999999999999999999863 35688889999888
Q ss_pred HhhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc---chhHHHhhcCCcc
Q 032061 80 VFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT---LSWYTTVIHEGLK 146 (148)
Q Consensus 80 l~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~---N~wv~~~T~g~I~ 146 (148)
+.. ....+.++|++|++++++++++|.+.++++|++++..+||.. ... |+||+++|+|+|+
T Consensus 90 l~~-----~~~~l~~an~i~v~~~~~l~~~f~~~~~~~~~~~~~~~~~~~-~~~~~IN~wv~~~T~g~I~ 153 (374)
T cd02052 90 LTA-----PAKGLKSASRILLERKLRLRLEFVNQVEKSYGERPRILAGNA-LDLQEINDWVQQQTGGKVD 153 (374)
T ss_pred hcC-----CCccchhhhHHHHhCCCchhHHHHHHHHHHhhCccccccCCH-HHHHHHHHHHHHhhcCcHH
Confidence 852 123689999999999999999999999999999999999854 222 9999999999996
No 18
>KOG2392 consensus Serpin [Defense mechanisms]
Probab=99.95 E-value=3.5e-27 Score=182.15 Aligned_cols=140 Identities=31% Similarity=0.478 Sum_probs=122.4
Q ss_pred HhhhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCCh---HHHHHHHHHHHHHH
Q 032061 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSD---DQLNTFASELVAVV 80 (148)
Q Consensus 4 ~~~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~---~~~~~~~~~l~~~l 80 (148)
..+.....+|+++||+++... .+++|+||||+||+.+|+|+++||.|.|++||+++|+++.. ..++..++.+...+
T Consensus 5 ~~~~~~~~~f~~~l~~~~~~~-~~~~Ni~fSP~SI~~aL~m~~lGa~g~T~~qi~~~L~~~~~~~~~~~~~~~~~~~~~~ 83 (380)
T KOG2392|consen 5 ASLSQSEADFALDLYRQLAKS-APDENVVFSPLSISSALAMVSLGAKGETADQILKALHFNSTDEENEVHESFQSLLLLL 83 (380)
T ss_pred hhhhhhhhHHHHHHHHHHHhh-CCCCCEEEChHHHHHHHHHHHhcCCccHHHHHHHHhCCCCCcchHHHHHHHHHHHHHh
Confidence 456677899999999999863 78999999999999999999999999999999999999842 45788888777633
Q ss_pred hhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCC-CCccc----chhHHHhhcCCccC
Q 032061 81 FADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQ-TKVKT----LSWYTTVIHEGLKF 147 (148)
Q Consensus 81 ~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~-~~~~~----N~wv~~~T~g~I~~ 147 (148)
. ....++.+.++|++|+++++.+.++|.+.++++|+++++.+||. +...+ |.||+++|+|+|+.
T Consensus 84 ~---~~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~~dF~~~~e~~~~~IN~wv~~~T~gkI~~ 152 (380)
T KOG2392|consen 84 N---STESGYELKLANRLFVSKSLKLLQKFLELVKKLYKAEAESLDFSNDTEEAAKEINEWVEEHTNGKIKD 152 (380)
T ss_pred c---cccCCceEEEeeeheecCCccccHHHHHHHHHHHhCcceeecCccChHHHHHHHHHHHHHHcCCchhh
Confidence 3 23456899999999999999999999999999999999999999 45554 99999999999973
No 19
>cd02055 PZI Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10). ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms.
Probab=99.95 E-value=7.5e-28 Score=185.31 Aligned_cols=133 Identities=16% Similarity=0.241 Sum_probs=113.0
Q ss_pred hhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCCh-----HHHHHHHHHHHHHH
Q 032061 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSD-----DQLNTFASELVAVV 80 (148)
Q Consensus 6 ~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-----~~~~~~~~~l~~~l 80 (148)
|+.+.++||++||+.+.. .+++|+|+||+||+.+|+|++.||+|.|+.||.++|+++.. .+++..++.+.+.+
T Consensus 2 ~~~~~~~Fa~~l~~~~~~--~~~~Nvv~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~~l~~~~ 79 (365)
T cd02055 2 FAEETANFGFNLLRKIAM--KHDGNIIFSPFGMSLAMAGLLLAAEGETERQIAKALHLHALKDRDPGLLPALFKGLKDNI 79 (365)
T ss_pred cchhhhHHHHHHHHHHhc--CCCCcEEEChHHHHHHHHHHHhhcCchHHHHHHHHcCCCCCccccHHHHHHHHHHHHHHh
Confidence 567889999999999975 35789999999999999999999999999999999998641 34666777777666
Q ss_pred hhCCCCCCCCeeEeee--eeeecCCCCCChhHHHHHHhhccccceEecCCCCccc----chhHHHhhcCCcc
Q 032061 81 FADGSPSGGPRLSVAN--GVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 81 ~~~~~~~~~~~l~~~n--~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~----N~wv~~~T~g~I~ 146 (148)
.. ...+.+++ .+|+++++.++++|.+.++++|++++..+||.++..+ |+||+++|+|+|+
T Consensus 80 ~~------~~~~~l~~~~~~~v~~~~~l~~~F~~~~~~~y~~~~~~vdF~~~~~a~~~IN~wv~~~T~g~I~ 145 (365)
T cd02055 80 SR------NEELGFTQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQNASQAKFLINHNIKKETKGKIP 145 (365)
T ss_pred cC------CcceehHHHHHHHHHCCCCccHHHHHHHHHHhcCeeEEECCCChHHHHHHHHHHHHHhhcchHH
Confidence 31 22344555 4599999999999999999999999999999887654 9999999999997
No 20
>smart00093 SERPIN SERine Proteinase INhibitors.
Probab=99.95 E-value=2.4e-27 Score=182.13 Aligned_cols=128 Identities=30% Similarity=0.484 Sum_probs=112.8
Q ss_pred HHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCCh----HHHHHHHHHHHHHHhhCCCCCCCC
Q 032061 15 LSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSD----DQLNTFASELVAVVFADGSPSGGP 90 (148)
Q Consensus 15 ~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~----~~~~~~~~~l~~~l~~~~~~~~~~ 90 (148)
++||+.+... ++++|+|+||+||+.+|+|++.||+|+|++||.++|+++.. .+++..++.+...+.. ...+.
T Consensus 1 ~~l~~~l~~~-~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~~---~~~~~ 76 (359)
T smart00093 1 FDLYKELAKE-SPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGFNLTELSEADIHQGFQHLLQLLNR---PDSQL 76 (359)
T ss_pred ChHHHHHhcc-CCCCeEEEChHHHHHHHHHHHcccCchHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHHhC---CCCcc
Confidence 3689999764 67899999999999999999999999999999999999742 3688889888888863 23456
Q ss_pred eeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCC-ccc----chhHHHhhcCCcc
Q 032061 91 RLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTK-VKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 91 ~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~-~~~----N~wv~~~T~g~I~ 146 (148)
.+.++|++|++++++++++|.+.++++|+++++.+||.++ ..+ |.||+++|+|+|+
T Consensus 77 ~l~~an~i~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~a~~~IN~wv~~~T~g~I~ 137 (359)
T smart00093 77 ELKTANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDKAEEAKKQINDWVEKKTQGKIK 137 (359)
T ss_pred eEEeeeeehccCCCchhHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhhhchHH
Confidence 8999999999999999999999999999999999999885 323 9999999999996
No 21
>cd02053 alpha2AP Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots. Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily.
Probab=99.94 E-value=1.6e-27 Score=182.68 Aligned_cols=130 Identities=23% Similarity=0.344 Sum_probs=107.8
Q ss_pred hhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCCCC
Q 032061 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVFADGSP 86 (148)
Q Consensus 7 ~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~ 86 (148)
..+.++|+++||+++... .+++|+|+||+||+.+|+|++.||+|.|++||.++|+++....+ ..+++.+.+ .
T Consensus 2 ~~~~~~F~~~l~~~~~~~-~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~----~~~~~~l~~---~ 73 (351)
T cd02053 2 ARAMMGFSTDLLSEVAQE-STKPNLILSPLSIALALSHLALGAQNETEQRLLKTLHAESLPCL----HHLLSRLRQ---D 73 (351)
T ss_pred CcchhhHHHHHHHHHHhh-CCCCcEEECcHHHHHHHHHHHhhcChHHHHHHHHhcCCCChHHH----HHHHHHHhc---c
Confidence 457899999999999864 67899999999999999999999999999999999999754333 344455542 2
Q ss_pred CCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCC-Cccc----chhHHHhhcCCcc
Q 032061 87 SGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQT-KVKT----LSWYTTVIHEGLK 146 (148)
Q Consensus 87 ~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~-~~~~----N~wv~~~T~g~I~ 146 (148)
..+..+.++|++|++++++++++|.+.++++|++++ +||.. +..+ |+||+++|+|+|+
T Consensus 74 ~~~~~l~~an~i~v~~~~~~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~IN~wv~~~T~g~I~ 136 (351)
T cd02053 74 LGPGALRLATRMYLQKGFEIKESFLEESEKLYGAKP--VSLTGTKEDDLANINKWVKEATEGQIP 136 (351)
T ss_pred CCccEeehhhHHHHhCCCchhHHHHHHHHHHcCCEE--eecCCCCHHHHHHHHHHHHHhccCchh
Confidence 234679999999999999999999999999999986 45532 3222 9999999999996
No 22
>cd02050 C1_inh C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family. It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily.
Probab=99.94 E-value=4.8e-27 Score=180.13 Aligned_cols=128 Identities=25% Similarity=0.377 Sum_probs=107.6
Q ss_pred hhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCCh-HHHHHHHHHHHHHHhhCCCCC
Q 032061 9 NQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSD-DQLNTFASELVAVVFADGSPS 87 (148)
Q Consensus 9 ~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~-~~~~~~~~~l~~~l~~~~~~~ 87 (148)
+.++||++||+++....++++|+|+||+||+.+|+||+.||+|.|++||.++|+++.. .+++..++.+.+
T Consensus 1 ~~~~F~~~l~~~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~l~~--------- 71 (352)
T cd02050 1 ALGEFSLKLYQHLSESAKPDTNLLFSPVSIALLLSHLLLGARGKTQRRLESILSYPHDFACVHSALKKLKN--------- 71 (352)
T ss_pred CcchHHHHHHHHHhhccCCCCCEEEChHHHHHHHHHHhcccCccHHHHHHHhcCCCCchhHHHHHHHHhhh---------
Confidence 3578999999999864227899999999999999999999999999999999999743 344444444322
Q ss_pred CCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc---chhHHHhhcCCcc
Q 032061 88 GGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT---LSWYTTVIHEGLK 146 (148)
Q Consensus 88 ~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~---N~wv~~~T~g~I~ 146 (148)
...+.++|+||++++++++++|.+.++++|++++..+||...... |+||+++|+|+|+
T Consensus 72 -~~~l~~an~i~~~~~~~l~~~f~~~~~~~y~~~~~~~~~~~~~a~~~IN~wv~~~T~g~I~ 132 (352)
T cd02050 72 -KLGLLSASQIFHHPDLHLRESFTNESWQFYKARPRELSNNSELNLEMINSWVAKATNNKIP 132 (352)
T ss_pred -cchhHHHHHHHHhCCCCccHHHHHHHHHHhCCcceeecCChHHHHHHHHHHHHHHhcchHH
Confidence 135889999999999999999999999999999999998643322 9999999999997
No 23
>PHA02948 serine protease inhibitor-like protein; Provisional
Probab=99.91 E-value=1.3e-24 Score=167.66 Aligned_cols=132 Identities=16% Similarity=0.213 Sum_probs=107.6
Q ss_pred hhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCCC
Q 032061 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVFADGS 85 (148)
Q Consensus 6 ~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~ 85 (148)
...+.++||++||+++... .+++|+||||+||+.+|+|++.||+|+|++||.++|+++. .+++..++.+.+.+...
T Consensus 17 ~~~~~~~f~~~l~~~l~~~-~~~~Nv~~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~-~~~~~~~~~l~~~~~~~-- 92 (373)
T PHA02948 17 RLQGFTNAGILAYKNIQDG-NEDDNIVFSPFGYSFSMFMSLLPASGNTRVELLKTMDLRK-RDLGPAFTELISGLAKL-- 92 (373)
T ss_pred hhccchHHHHHHHHHHHhc-CCCCCEEEchHHHHHHHHHHHhccCCcHHHHHHHHhCCCc-hhHHHHHHHHHHHHhcc--
Confidence 3457889999999999764 5788999999999999999999999999999999999874 46778888888777531
Q ss_pred CCCCCe-eEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCccc--chhHHHhhcCCcc
Q 032061 86 PSGGPR-LSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKVKT--LSWYTTVIHEGLK 146 (148)
Q Consensus 86 ~~~~~~-l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~--N~wv~~~T~g~I~ 146 (148)
...+.. +.++|++|+++++.++++|.+ ++|++++..+||.+.... |+||+++| +|+
T Consensus 93 ~~~~~~~~~~an~~~v~~~~~~~~~f~~---~~~~~~v~~vdF~~~a~~~IN~WV~~~T--~I~ 151 (373)
T PHA02948 93 KTSKYTYTDLTYQSFVDNTVCIKPSYYQ---QYHRFGLYRLNFRRDAVNKINSIVERRS--GMS 151 (373)
T ss_pred cccCcchHHHHHHHHHhcCCCccHHHHH---HHhhCceEecCccHHHHHHHHHHHHhcC--CCc
Confidence 112333 468999999999999999987 456789999999743222 99999998 464
No 24
>PHA02660 serpin-like protein; Provisional
Probab=99.87 E-value=1.2e-22 Score=156.41 Aligned_cols=115 Identities=17% Similarity=0.319 Sum_probs=96.8
Q ss_pred hhhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCC
Q 032061 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVFADG 84 (148)
Q Consensus 5 ~~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~ 84 (148)
..+....+||++||+++. ++|+|+||+||+.+|+|++.||+|+|+.||.++|++... . +.
T Consensus 10 ~~~~~~~~f~~~l~~~~~-----~~Nvv~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~-~-----------~~--- 69 (364)
T PHA02660 10 NIIKMSLDLGFCILKSLH-----RFNIVFSPESLKAFLHVLYLGSERETKNELSKYIGHAYS-P-----------IR--- 69 (364)
T ss_pred hHHHHHHHHHHHHHHhcC-----CCCEEEChHHHHHHHHHHHhhcCchHHHHHHHHhCcccc-c-----------cc---
Confidence 356778999999999994 379999999999999999999999999999999987521 0 00
Q ss_pred CCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccccceEecCCCCc-cc----chhHHHhhcCCcc
Q 032061 85 SPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAASNQVDFQTKV-KT----LSWYTTVIHEGLK 146 (148)
Q Consensus 85 ~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~-~~----N~wv~~~T~g~I~ 146 (148)
...+.++|++|++++++++++|.+.+++ |++++..+||.+.+ .+ |.||+++|+ |+
T Consensus 70 ----~~~l~~an~l~v~~~~~l~~~F~~~~~~-~~~~v~~vdF~~~~~~a~~~IN~WV~~~T~--I~ 129 (364)
T PHA02660 70 ----KNHIHNITKVYVDSHLPIHSAFVASMND-MGIDVILADLANHAEPIRRSINEWVYEKTN--II 129 (364)
T ss_pred ----hhhHHHHHHHHHhcCCchhHHHHHHHHH-cCCceEEeccccCHHHHHHHHHHHHHhccC--Cc
Confidence 1124568999999999999999999987 89999999997643 23 999999998 65
No 25
>PF04079 DUF387: Putative transcriptional regulators (Ypuh-like); InterPro: IPR005234 This family represents ScpB, which along with ScpA (IPR003768 from INTERPRO) interacts with SMC in vivo forming a complex that is required for chromosome condensation and segregation [, ]. The SMC-Scp complex appears to be similar to the MukB-MukE-Muk-F complex in Escherichia coli [], where MukB (IPR007406 from INTERPRO) is the homologue of SMC. ScpA and ScpB have little sequence similarity to MukE (IPR007385 from INTERPRO) or MukF (IPR005582 from INTERPRO), they are predicted to be structurally similar, being predominantly alpha-helical with coiled coil regions. In general scpA and scpB form an operon in most bacterial genomes. Flanking genes are highly variable suggesting that the operon has moved throughout evolution. Bacteria containing an smc gene also contain scpA or scpB but not necessarily both. An exception is found in Deinococcus radiodurans, which contains scpB but neither smc nor scpA. In the archaea the gene order SMC-ScpA is conserved in nearly all species, as is the very short distance between the two genes, indicating co-transcription of the both in different archaeal genera and arguing that interaction of the gene products is not confined to the homologues in Bacillus subtilis. It would seem probable that, in light of all the studies, SMC, ScpA and ScpB proteins or homologues act together in chromosome condensation and segregation in all prokaryotes []. ; GO: 0051304 chromosome separation; PDB: 1T6S_B 2Z99_A.
Probab=77.52 E-value=13 Score=25.52 Aligned_cols=72 Identities=21% Similarity=0.324 Sum_probs=47.5
Q ss_pred HHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccc
Q 032061 41 LLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKA 120 (148)
Q Consensus 41 ~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~ 120 (148)
.=|+|+....+-+..+|.++++ +..++......|...... ...+..+.....-|. +..+++|...+++++..
T Consensus 3 iEAlLF~s~~pvs~~~La~~l~--~~~~v~~~l~~L~~~y~~---~~~gl~l~~~~~~y~---l~tk~~~~~~v~~~~~~ 74 (159)
T PF04079_consen 3 IEALLFASGEPVSIEELAEILG--SEDEVEEALEELQEEYNE---EDRGLELVEVGGGYR---LQTKPEYAEYVEKLFKK 74 (159)
T ss_dssp HHHHHHH-SS-B-HHHHHHHCT---HHHHHHHHHHHHHHHHH---CT-SEEEEEETTEEE---EEE-GGGHHHHHHHHCT
T ss_pred hHhhHHHcCCCCCHHHHHHHhC--CHHHHHHHHHHHHHHhcc---CCCCEEEEEECCEEE---EEEhHHHHHHHHHHhcc
Confidence 3467788888899999999999 456788888888888753 234555555444443 36678888888887765
No 26
>PTZ00100 DnaJ chaperone protein; Provisional
Probab=77.14 E-value=17 Score=23.64 Aligned_cols=70 Identities=10% Similarity=0.104 Sum_probs=51.6
Q ss_pred HHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHH----cC--CCCchHHHHHHhcCCCC---hHHHHHHHHHHHHHHh
Q 032061 11 TDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLIS----AG--SKGPTLDQLLSFLKSKS---DDQLNTFASELVAVVF 81 (148)
Q Consensus 11 ~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~----~g--a~g~T~~el~~~L~~~~---~~~~~~~~~~l~~~l~ 81 (148)
...+++.+++... .+..|..+.|-++...+.-++ ++ -..-|..|..++|+++. .+++...|+++....+
T Consensus 17 ~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~~~~~~~~~~~~~f~~~Ms~~eAy~ILGv~~~As~~eIkkaYRrLa~~~H 94 (116)
T PTZ00100 17 VRYGYRYLKNQKI--FGSNNMSFPLSGFNPSLGSLFLKNDLKGFENPMSKSEAYKILNISPTASKERIREAHKQLMLRNH 94 (116)
T ss_pred HHHHHHHHHHHhh--ccCccccCCchhhhHHHHHHHhccccccccCCCCHHHHHHHcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 3456666776554 577898998888888887766 33 34556789999999874 3678889998887776
Q ss_pred h
Q 032061 82 A 82 (148)
Q Consensus 82 ~ 82 (148)
.
T Consensus 95 P 95 (116)
T PTZ00100 95 P 95 (116)
T ss_pred C
Confidence 4
No 27
>TIGR00281 segregation and condensation protein B. Shown to be required for chromosome segregation and condensation in B. subtilis.
Probab=67.68 E-value=41 Score=23.81 Aligned_cols=75 Identities=19% Similarity=0.261 Sum_probs=46.0
Q ss_pred HHHHcCCC-CchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhcccc
Q 032061 43 SLISAGSK-GPTLDQLLSFLKSKSDDQLNTFASELVAVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAA 121 (148)
Q Consensus 43 ~~l~~ga~-g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~~ 121 (148)
|+|+.... |-|..+|.++++......+......+...... .+.+..+.-.+.-|. +..+++|...+.+++...
T Consensus 8 AlLF~sg~pgls~~~La~il~~~~~~~~~~~l~~l~~~~~~---~~~gl~l~~~~~~y~---l~tk~e~~~~i~~~~~~~ 81 (186)
T TIGR00281 8 ALLFVSGEPGVTLAELVRILGKEKAEKLNAIMELLEDYLSR---DTAGIEIIKFGQSYS---LVTKPAFADYIHRFLPAK 81 (186)
T ss_pred HHHHHcCCCCCCHHHHHHHhCCCchHHHHHHHHHHHHHHhc---CCCCEEEEEECCEEE---EEEhHHHHHHHHHHhccc
Confidence 45555445 58999999999876443444444444444331 223455544445553 477899999998887655
Q ss_pred ce
Q 032061 122 SN 123 (148)
Q Consensus 122 ~~ 123 (148)
..
T Consensus 82 ~~ 83 (186)
T TIGR00281 82 LK 83 (186)
T ss_pred cc
Confidence 43
No 28
>COG1386 scpB Chromosome segregation and condensation protein B [DNA replication, recombination and repair]
Probab=63.96 E-value=44 Score=23.63 Aligned_cols=69 Identities=20% Similarity=0.240 Sum_probs=41.0
Q ss_pred HHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhcc
Q 032061 43 SLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYK 119 (148)
Q Consensus 43 ~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~ 119 (148)
++++.|..+-|..+|.++|+......+......+..... ..+..+.....-|-- ..++.|.+.+.++..
T Consensus 15 all~a~~~pls~~~L~~il~~~~~~~~~~~l~~l~~~y~-----~rg~~L~~~~~~~r~---~t~~~~~~~~~~l~~ 83 (184)
T COG1386 15 ALLFAGGEPLSLKELAEILGIVSADAIIDALAELKEEYE-----DRGLELVEVAEGWRL---QTKQEYAEYLEKLQE 83 (184)
T ss_pred HHHHhcCCCCCHHHHHHHhCCCchHHHHHHHHHHHHhhc-----CCCeeEEEEcCceeE---EehHHHHHHHHHHhc
Confidence 567788899999999999998633345555555544432 345555555444432 334445444444433
No 29
>PRK00135 scpB segregation and condensation protein B; Reviewed
Probab=63.67 E-value=50 Score=23.39 Aligned_cols=71 Identities=21% Similarity=0.275 Sum_probs=46.3
Q ss_pred HHHHcCCC-CchHHHHHHhcCCCChHHHHHHHHHHHHHHhhCCCCCCCCeeEeeeeeeecCCCCCChhHHHHHHhhccc
Q 032061 43 SLISAGSK-GPTLDQLLSFLKSKSDDQLNTFASELVAVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKA 120 (148)
Q Consensus 43 ~~l~~ga~-g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~~~~~l~~~n~l~~~~~~~~~~~f~~~~~~~y~~ 120 (148)
|+|+.... |-+..+|.++++.. ..++......|...... ...+..+.-...-|. +..+++|...+++++..
T Consensus 11 A~LF~sg~pgls~~~La~~l~~~-~~~v~~~l~~L~~~y~~---~~~gi~i~~~~~~y~---l~tk~e~~~~v~~~~~~ 82 (188)
T PRK00135 11 ALLFVSGEEGLSLEQLAEILELE-PTEVQQLLEELQEKYEG---DDRGLKLIEFNDVYK---LVTKEENADYLQKLVKT 82 (188)
T ss_pred HHHHHcCCCCCCHHHHHHHHCCC-HHHHHHHHHHHHHHHhh---CCCCEEEEEECCEEE---EEEcHHHHHHHHHHhcc
Confidence 44444444 57999999999876 34567777777666642 233455544444454 46789999888887654
No 30
>COG1510 Predicted transcriptional regulators [Transcription]
Probab=56.37 E-value=26 Score=24.52 Aligned_cols=42 Identities=14% Similarity=0.165 Sum_probs=32.7
Q ss_pred cccHHHHHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHH
Q 032061 35 PSSIHVLLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELV 77 (148)
Q Consensus 35 P~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~ 77 (148)
|-++....|++|+....-|.+||.+++|++.. .+....+.|.
T Consensus 25 nrtVG~iYgilyls~~Pmtl~Ei~E~lg~Sks-~vS~~lkkL~ 66 (177)
T COG1510 25 NRTVGQIYGILYLSRKPLTLDEIAEALGMSKS-NVSMGLKKLQ 66 (177)
T ss_pred cchHHHHhhhheecCCCccHHHHHHHHCCCcc-hHHHHHHHHH
Confidence 45678899999999999999999999999742 3444444443
No 31
>PF13766 ECH_C: 2-enoyl-CoA Hydratase C-terminal region; PDB: 3JU1_A 3BPT_A.
Probab=56.20 E-value=38 Score=21.93 Aligned_cols=37 Identities=16% Similarity=0.153 Sum_probs=27.2
Q ss_pred hhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCC
Q 032061 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKG 51 (148)
Q Consensus 6 ~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g 51 (148)
|......|+-+-.+.+.. . ||+|+..++.++..|..-
T Consensus 25 L~~~~~~~a~~~~~~l~~----~-----SP~Sl~vt~~~l~~~~~~ 61 (118)
T PF13766_consen 25 LEADGDEWAQKTLETLRS----G-----SPLSLKVTFEQLRRGRNL 61 (118)
T ss_dssp HHHHS-HHHHHHHHHHCC----S------HHHHHHHHHHHHCCTTS
T ss_pred HHccCcHHHHHHHHHHHH----C-----CHHHHHHHHHHHHHhhhC
Confidence 444556778777787753 2 899999999999999883
No 32
>PF01726 LexA_DNA_bind: LexA DNA binding domain; InterPro: IPR006199 This is the DNA binding domain of the LexA SOS regulon repressor which prevents expression of DNA repair proteins in bacteria. The aligned region contains a variant form of the helix-turn-helix DNA binding motif []. This domain usually at the N terminus is found associated with IPR006198 from INTERPRO the auto-proteolytic domain of LexA 3.4.21.88 from EC.; GO: 0004252 serine-type endopeptidase activity, 0006508 proteolysis; PDB: 1LEA_A 1JHH_A 3JSP_A 1JHF_A 3JSO_B 1LEB_A 3K2Z_A.
Probab=52.73 E-value=31 Score=19.80 Aligned_cols=27 Identities=22% Similarity=0.262 Sum_probs=18.6
Q ss_pred CchHHHHHHhcCCCChHHHHHHHHHHH
Q 032061 51 GPTLDQLLSFLKSKSDDQLNTFASELV 77 (148)
Q Consensus 51 g~T~~el~~~L~~~~~~~~~~~~~~l~ 77 (148)
.+|-.||.+.|++.+...++...+.|-
T Consensus 25 ~Pt~rEIa~~~g~~S~~tv~~~L~~Le 51 (65)
T PF01726_consen 25 PPTVREIAEALGLKSTSTVQRHLKALE 51 (65)
T ss_dssp ---HHHHHHHHTSSSHHHHHHHHHHHH
T ss_pred CCCHHHHHHHhCCCChHHHHHHHHHHH
Confidence 478899999999987777776655443
No 33
>PRK10046 dpiA two-component response regulator DpiA; Provisional
Probab=46.51 E-value=57 Score=23.11 Aligned_cols=41 Identities=10% Similarity=0.165 Sum_probs=32.6
Q ss_pred EccccHHHHHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHH
Q 032061 33 FSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFAS 74 (148)
Q Consensus 33 ~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~ 74 (148)
++|++....|.++..|..|.|..||.+.|++. ...+..+..
T Consensus 159 ~~~Lt~r~Vl~~~~~g~~g~s~~eIa~~l~iS-~~Tv~~~~~ 199 (225)
T PRK10046 159 IDPLTLNAVRKLFKEPGVQHTAETVAQALTIS-RTTARRYLE 199 (225)
T ss_pred CCHHHHHHHHHHHHcCCCCcCHHHHHHHhCcc-HHHHHHHHH
Confidence 46677778899999999999999999999987 345565544
No 34
>PF14679 FANCI_HD1: FANCI helical domain 1; PDB: 3S51_A 3S4Z_A 3S4W_A.
Probab=45.98 E-value=5.3 Score=24.62 Aligned_cols=47 Identities=28% Similarity=0.364 Sum_probs=25.6
Q ss_pred HHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHHcCCCCchHHHHHHhcC
Q 032061 12 DVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK 62 (148)
Q Consensus 12 ~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~ 62 (148)
+.|-++.+.+... ...-..++|||+++.+|++... ..=.+|+.+.|+
T Consensus 1 eLgrE~lk~lK~~-~~~p~~~L~pF~vallLsvarI---~Rfeeqvfd~Lk 47 (87)
T PF14679_consen 1 ELGRELLKYLKSD-QGDPERALSPFSVALLLSVARI---QRFEEQVFDFLK 47 (87)
T ss_dssp HHHHHHHHHH--S-SHHHHHH--HHHHHHHHHHTTS---GGGHHHHHHHHH
T ss_pred ChHHHHHHHHHhc-ccCCccccChHHHHHHHHHHHH---HHHHHHHHHHHH
Confidence 3566777777542 1223568899999988876543 233445555553
No 35
>KOG1597 consensus Transcription initiation factor TFIIB [Transcription]
Probab=39.49 E-value=68 Score=24.52 Aligned_cols=47 Identities=13% Similarity=0.049 Sum_probs=32.6
Q ss_pred EccccHHHHHHHHH--cCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHH
Q 032061 33 FSPSSIHVLLSLIS--AGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVV 80 (148)
Q Consensus 33 ~SP~si~~~L~~l~--~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l 80 (148)
=||.||+.+.--+. +-...+|..||..+.+.. +..+...|+.|+...
T Consensus 240 RsPiSIAAa~IYmisqls~~kkt~keI~~vtgVa-E~TIr~sYK~Lyp~~ 288 (308)
T KOG1597|consen 240 RSPISIAAAAIYMISQLSDEKKTQKEIGEVTGVA-EVTIRNSYKDLYPHA 288 (308)
T ss_pred CCchhHHHHHHHHHHHhccCcccHHHHHHHhhhh-HHHHHHHHHHHhhch
Confidence 37999886543222 344889999999999886 346777777766543
No 36
>PRK13870 transcriptional regulator TraR; Provisional
Probab=33.68 E-value=76 Score=23.08 Aligned_cols=39 Identities=10% Similarity=0.056 Sum_probs=28.7
Q ss_pred HHHHHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHH
Q 032061 41 LLSLISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVV 80 (148)
Q Consensus 41 ~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l 80 (148)
=.-.|.--|.|+|..||...|+++ ...|....++....+
T Consensus 178 E~E~L~W~A~GKT~~EIa~ILgIS-e~TV~~Hl~na~~KL 216 (234)
T PRK13870 178 EATYLRWIAVGKTMEEIADVEGVK-YNSVRVKLREAMKRF 216 (234)
T ss_pred HHHHHHHHHcCCCHHHHHHHHCCC-HHHHHHHHHHHHHHc
Confidence 345677788999999999999997 345666565555544
No 37
>PF09186 DUF1949: Domain of unknown function (DUF1949); InterPro: IPR015269 Members of this entry are a set of functionally uncharacterised hypothetical bacterial proteins. They adopt a ferredoxin-like fold, with a beta-alpha-beta-beta-alpha-beta arrangement []. This entry contains the protein Impact, which is a translational regulator that ensures constant high levels of translation under amino acid starvation. It acts by interacting with Gcn1/Gcn1L1, thereby preventing activation of Gcn2 protein kinases (EIF2AK1 to 4) and subsequent down-regulation of protein synthesis. It is evolutionary conserved from eukaryotes to archaea []. ; PDB: 2CVE_A 1VI7_A.
Probab=31.93 E-value=61 Score=17.25 Aligned_cols=36 Identities=8% Similarity=0.118 Sum_probs=21.8
Q ss_pred hhHHHHHHhhccccceEecCCCCccc------------chhHHHhhcCC
Q 032061 108 NTFKQVVDNVYKAASNQVDFQTKVKT------------LSWYTTVIHEG 144 (148)
Q Consensus 108 ~~f~~~~~~~y~~~~~~~df~~~~~~------------N~wv~~~T~g~ 144 (148)
..+...+.+ ++..+...+|.+.... .+++.+.|+|+
T Consensus 9 ~~v~~~l~~-~~~~i~~~~y~~~V~~~v~v~~~~~~~f~~~l~~~t~G~ 56 (56)
T PF09186_consen 9 GKVERLLEQ-NGIEIVDEDYTDDVTLTVAVPEEEVEEFKAQLTDLTSGR 56 (56)
T ss_dssp HHHHHHHHH-TTTEEEEEEECTTEEEEEEEECCCHHHHHHHHHHHTTT-
T ss_pred HHHHHHHHH-CCCEEEcceecceEEEEEEECHHHHHHHHHHHHHHcCCC
Confidence 344444544 5677777777665442 67777788775
No 38
>PF11124 Pho86: Inorganic phosphate transporter Pho86; InterPro: IPR024297 Pho86p is an ER protein which is produced in response to phosphate starvation. It is essential for growth when phosphate levels are limiting []. Pho86p is also involved in the regulation of Pho84p, a high-affinity phosphate transporter, which is localised to the endoplasmic reticulum (ER) in low phosphate medium. When the level of phosphate increases Pho84p is transported to the vacuole. Pho86p is required for packaging of Pho84p in to COPII vesicles [].
Probab=27.15 E-value=1.2e+02 Score=23.37 Aligned_cols=40 Identities=15% Similarity=0.258 Sum_probs=32.3
Q ss_pred hhhhhhHHHHHHHHHHHHhccCCCCcEEEccccHHHHHHHHH
Q 032061 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLIS 46 (148)
Q Consensus 5 ~~~~~~~~F~~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~ 46 (148)
+++.+.-.+..+.|+|... .-++-++..|+++......+.
T Consensus 26 ElAtAALnL~gD~~kQ~Qs--~~Nk~l~wHPi~~~~~~~~~~ 65 (304)
T PF11124_consen 26 ELATAALNLHGDFYKQLQS--LLNKYLFWHPITISVIVLVLP 65 (304)
T ss_pred HHHHHHHHhhHHHHHHHHH--HhcceeEeccHHHHHHHHHHH
Confidence 5678888899999999876 467899999999887665543
No 39
>PF01851 PC_rep: Proteasome/cyclosome repeat; InterPro: IPR002015 A weakly conserved repeat module of unknown function, which occurs in two regulatory subunits of the 26S-proteasome and in one subunit of the APC-complex (cyclosome) [].; PDB: 4ADY_A.
Probab=26.29 E-value=94 Score=15.28 Aligned_cols=26 Identities=38% Similarity=0.447 Sum_probs=16.3
Q ss_pred HHHHHHHHcCCCCc-hHHHHHHhcCCC
Q 032061 39 HVLLSLISAGSKGP-TLDQLLSFLKSK 64 (148)
Q Consensus 39 ~~~L~~l~~ga~g~-T~~el~~~L~~~ 64 (148)
..+|++.+.|+..+ ..+.|...+.-.
T Consensus 3 ~lgLGl~~aGs~~~~~~~~L~~~l~~~ 29 (35)
T PF01851_consen 3 ILGLGLIYAGSGNEEVLDLLRPYLSDT 29 (35)
T ss_dssp HHHHHHHTTTT--HHHHHHHHHHHCTS
T ss_pred HHHHHHHHcCCCCHHHHHHHHHHHHhc
Confidence 46788999988777 555666665433
No 40
>COG5567 Predicted small periplasmic lipoprotein [Cell motility and secretion]
Probab=25.72 E-value=24 Score=19.74 Aligned_cols=24 Identities=38% Similarity=0.523 Sum_probs=16.9
Q ss_pred CcEEEccccHHHHHHHHHcCCCCc
Q 032061 29 SNLVFSPSSIHVLLSLISAGSKGP 52 (148)
Q Consensus 29 ~N~v~SP~si~~~L~~l~~ga~g~ 52 (148)
+|.+-|++.+...+++...|-+|+
T Consensus 2 k~~~~s~~ala~l~sLA~CG~KGP 25 (58)
T COG5567 2 KNVFKSLLALATLFSLAGCGLKGP 25 (58)
T ss_pred hhHHHHHHHHHHHHHHHhcccCCC
Confidence 355667888877777777777765
No 41
>PF00832 Ribosomal_L39: Ribosomal L39 protein; InterPro: IPR000077 Ribosomes are the particles that catalyse mRNA-directed protein synthesis in all organisms. The codons of the mRNA are exposed on the ribosome to allow tRNA binding. This leads to the incorporation of amino acids into the growing polypeptide chain in accordance with the genetic information. Incoming amino acid monomers enter the ribosomal A site in the form of aminoacyl-tRNAs complexed with elongation factor Tu (EF-Tu) and GTP. The growing polypeptide chain, situated in the P site as peptidyl-tRNA, is then transferred to aminoacyl-tRNA and the new peptidyl-tRNA, extended by one residue, is translocated to the P site with the aid the elongation factor G (EF-G) and GTP as the deacylated tRNA is released from the ribosome through one or more exit sites [, ]. About 2/3 of the mass of the ribosome consists of RNA and 1/3 of protein. The proteins are named in accordance with the subunit of the ribosome which they belong to - the small (S1 to S31) and the large (L1 to L44). Usually they decorate the rRNA cores of the subunits. Many ribosomal proteins, particularly those of the large subunit, are composed of a globular, surfaced-exposed domain with long finger-like projections that extend into the rRNA core to stabilise its structure. Most of the proteins interact with multiple RNA elements, often from different domains. In the large subunit, about 1/3 of the 23S rRNA nucleotides are at least in van der Waal's contact with protein, and L22 interacts with all six domains of the 23S rRNA. Proteins S4 and S7, which initiate assembly of the 16S rRNA, are located at junctions of five and four RNA helices, respectively. In this way proteins serve to organise and stabilise the rRNA tertiary structure. While the crucial activities of decoding and peptide transfer are RNA based, proteins play an active role in functions that may have evolved to streamline the process of protein synthesis. In addition to their function in the ribosome, many ribosomal proteins have some function 'outside' the ribosome [, ]. A number of eukaryotic and archaebacterial large subunit ribosomal proteins can be grouped on the basis of sequence similarities. These proteins are very basic. About 50 residues long, they are the smallest proteins of eukaryotic-type ribosomes.; GO: 0003735 structural constituent of ribosome, 0006412 translation, 0005622 intracellular, 0005840 ribosome; PDB: 3CCJ_2 3CME_2 3OW2_1 1YI2_2 1KD1_3 3CXC_1 3G6E_2 1VQ4_2 3CCU_2 3CC7_2 ....
Probab=25.69 E-value=37 Score=17.99 Aligned_cols=14 Identities=7% Similarity=0.403 Sum_probs=10.3
Q ss_pred chhHHHhhcCCccC
Q 032061 134 LSWYTTVIHEGLKF 147 (148)
Q Consensus 134 N~wv~~~T~g~I~~ 147 (148)
=.||.-.|+++|.|
T Consensus 16 P~Wv~~kT~~kiry 29 (43)
T PF00832_consen 16 PQWVRMKTGNKIRY 29 (43)
T ss_dssp -HHGHHCTTSS-SS
T ss_pred CcEEEEeCCCceee
Confidence 36999999999876
No 42
>KOG0716 consensus Molecular chaperone (DnaJ superfamily) [Posttranslational modification, protein turnover, chaperones]
Probab=25.57 E-value=1.5e+02 Score=22.49 Aligned_cols=38 Identities=16% Similarity=0.099 Sum_probs=29.6
Q ss_pred CCCchHHHHHHhcCCCC---hHHHHHHHHHHHHHHhhCCCC
Q 032061 49 SKGPTLDQLLSFLKSKS---DDQLNTFASELVAVVFADGSP 86 (148)
Q Consensus 49 a~g~T~~el~~~L~~~~---~~~~~~~~~~l~~~l~~~~~~ 86 (148)
+.+.++..+.+|||++. .+++.+.|+.+....+.+.++
T Consensus 25 ~~~~~~~~LYdVLgl~k~at~d~IKKaYR~L~~k~HPD~~g 65 (279)
T KOG0716|consen 25 SEDVIRLDLYDVLGLPKTATKDEIKKAYRKLALKYHPDKNG 65 (279)
T ss_pred ccccchhHHHHHhCCCcccchHHHHHHHHHHHHHhCCCcCC
Confidence 67778889999999984 256888999998888765433
No 43
>PF00196 GerE: Bacterial regulatory proteins, luxR family; InterPro: IPR000792 This domain is a DNA-binding, helix-turn-helix (HTH) domain of about 65 amino acids, present in transcription regulators of the LuxR/FixJ family of response regulators. The domain is named after Vibrio fischeri luxR, a transcriptional activator for quorum-sensing control of luminescence. LuxR-type HTH domain proteins occur in a variety of organisms. The DNA-binding HTH domain is usually located in the C-terminal region; the N-terminal region often containing an autoinducer-binding domain or a response regulatory domain. Most luxR-type regulators act as transcription activators, but some can be repressors or have a dual role for different sites. LuxR-type HTH regulators control a wide variety of activities in various biological processes. The luxR-type, DNA-binding HTH domain forms a four-helical bundle structure. The HTH motif comprises the second and third helices, known as the scaffold and recognition helix, respectively. The HTH binds DNA in the major groove, where the N-terminal part of the recognition helix makes most of the DNA contacts. The fourth helix is involved in dimerisation of gerE and traR. Signalling events by one of the four activation mechanisms described below lead to multimerisation of the regulator. The regulators bind DNA as multimers [, , ]. LuxR-type HTH proteins can be activated by one of four different mechanisms: 1) Regulators which belong to a two-component sensory transduction system where the protein is activated by its phosphorylation, generally on an aspartate residue, by a transmembrane kinase [, ]. Some proteins that belong to this category are: Rhizobiaceae fixJ (global regulator inducing expression of nitrogen-fixation genes in microaerobiosis) Escherichia coli and Salmonella typhimurium uhpA (activates hexose phosphate transport gene uhpT) E. coli narL and narP (activate nitrate reductase operon) Enterobacteria rcsB (regulation of exopolysaccharide biosynthesis in enteric and plant pathogenesis) Bordetella pertussis bvgA (virulence factor) Bacillus subtilis coma (involved in expression of late-expressing competence genes) 2) Regulators which are activated, or in very rare cases repressed, when bound to N-acyl homoserine lactones, which are used as quorum sensing molecules in a variety of Gram-negative bacteria []: V. fischeri luxR (activates bioluminescence operon) Agrobacterium tumefaciens traR (regulation of Ti plasmid transfer) Erwinia carotovora carR (control of carbapenem antibiotics biosynthesis) E. carotovora expR (virulence factor for soft rot disease; activates plant tissue macerating enzyme genes) Pseudomonas aeruginosa lasR (activates elastase gene lasB) Erwinia chrysanthemi echR and Erwinia stewartii esaR Pseudomonas chlororaphis phzR (positive regulator of phenazine antibiotic production) Pseudomonas aeruginosa rhlR (activates rhlAB operon and lasB gene) 3) Autonomous effector domain regulators, without a regulatory domain, represented by gerE []. B. subtilis gerE (transcription activator and repressor for the regulation of spore formation) 4) Multiple ligand-binding regulators, exemplified by malT []. E. coli malT (activates maltose operon; MalT binds ATP and maltotriose); GO: 0003700 sequence-specific DNA binding transcription factor activity, 0043565 sequence-specific DNA binding, 0006355 regulation of transcription, DNA-dependent, 0005622 intracellular; PDB: 3SZT_A 3CLO_A 1H0M_A 1L3L_A 3C57_B 1ZLK_B 1ZLJ_H 3C3W_B 1RNL_A 1ZG1_A ....
Probab=24.76 E-value=1.2e+02 Score=16.36 Aligned_cols=37 Identities=5% Similarity=0.102 Sum_probs=25.6
Q ss_pred HHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHh
Q 032061 44 LISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVF 81 (148)
Q Consensus 44 ~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~ 81 (148)
++..-+.|.+..||.+.|+.+ ...+....+.+...+.
T Consensus 11 vl~~l~~G~~~~eIA~~l~is-~~tV~~~~~~i~~Kl~ 47 (58)
T PF00196_consen 11 VLRLLAQGMSNKEIAEELGIS-EKTVKSHRRRIMKKLG 47 (58)
T ss_dssp HHHHHHTTS-HHHHHHHHTSH-HHHHHHHHHHHHHHHT
T ss_pred HHHHHHhcCCcchhHHhcCcc-hhhHHHHHHHHHHHhC
Confidence 444556789999999999886 4467776667766653
No 44
>PF08672 APC2: Anaphase promoting complex (APC) subunit 2; InterPro: IPR014786 The anaphase-promoting complex (APC) or cyclosome is a multi-subunit E3 protein ubiquitin ligase that regulates important events in mitosis such as the initiation of anaphase and exit from telophase. The APC, in conjunction with other enzymes, assembles multi-ubiquitin chains on a variety of regulatory proteins, thereby targeting them for proteolysis by the 26S proteasome. Anaphase is initiated when the APC triggers the destruction of securin, thereby allowing the protease, separase, to disrupt sister-chromatid cohesion. Securin ubiquitination by the APC is inhibited by cyclin-dependent kinase 1 (Cdk1)-dependent phosphorylation []. Forkhead Box M1 (FoxM1), which is a transcription factor that is over-expressed in many cancers, is degraded in late mitosis and early G1 phase by the APC/cyclosome (APC/C) E3 ubiquitin ligase []. The APC/C targets mitotic cyclins for destruction in mitosis and G1 phase and is then inactivated at S phase. It thereby generates alternating states of high and low cyclin-Cdk activity, which is required for the alternation of mitosis and DNA replication []. The APC/C is composed of at least 13 subunits that stay tightly associated throughout the cell cycle: APC1, APC2, APC4, APC5, APC9, APC11, CDC16, CDC23, CDC26, CDC27, DOC1, MND2 and SWM1[], []. In fission yeast the 13 subunits are known as: Apc1, Apc2, Nuc2, Apc4, Apc5, Cut9, Apc8, Apc10, Apc11, Hcn1, Apc13, Apc14 and Apc15 []. This entry represents a C-terminal domain found in APC subunit 2. ; PDB: 1LDD_A.
Probab=23.54 E-value=1.2e+02 Score=17.18 Aligned_cols=23 Identities=30% Similarity=0.615 Sum_probs=8.3
Q ss_pred HHHHHHHH--HcCCCCchHHHHHHh
Q 032061 38 IHVLLSLI--SAGSKGPTLDQLLSF 60 (148)
Q Consensus 38 i~~~L~~l--~~ga~g~T~~el~~~ 60 (148)
|...|-|+ ..+..+.|.+|++..
T Consensus 17 Ih~mLkmf~~~~~~~~~s~~eL~~f 41 (60)
T PF08672_consen 17 IHSMLKMFPKDPGGYDISLEELQEF 41 (60)
T ss_dssp HHHHHHHH-GGG--TT--HHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Confidence 44555555 233333444444433
No 45
>PF12802 MarR_2: MarR family; PDB: 3ECO_B 2QWW_B 3KP6_B 3KP4_B 3KP2_A 3KP5_A 3KP3_B 3KP7_A 3NQO_B 3K0L_B ....
Probab=23.22 E-value=1.4e+02 Score=16.10 Aligned_cols=33 Identities=12% Similarity=0.119 Sum_probs=19.1
Q ss_pred HHHHHH-cCCCCchHHHHHHhcCCCChHHHHHHHH
Q 032061 41 LLSLIS-AGSKGPTLDQLLSFLKSKSDDQLNTFAS 74 (148)
Q Consensus 41 ~L~~l~-~ga~g~T~~el~~~L~~~~~~~~~~~~~ 74 (148)
+|..++ .+-.+-|..||.+.++++. ..+....+
T Consensus 10 vL~~l~~~~~~~~t~~~la~~l~~~~-~~vs~~v~ 43 (62)
T PF12802_consen 10 VLMALARHPGEELTQSELAERLGISK-STVSRIVK 43 (62)
T ss_dssp HHHHHHHSTTSGEEHHHHHHHHTS-H-HHHHHHHH
T ss_pred HHHHHHHCCCCCcCHHHHHHHHCcCH-HHHHHHHH
Confidence 333333 3333469999999999873 34444433
No 46
>PF00325 Crp: Bacterial regulatory proteins, crp family; InterPro: IPR001808 Numerous bacterial transcription regulatory proteins bind DNA via a helix-turn-helix (HTH) motif. These proteins are very diverse, but for convenience may be grouped into subfamilies on the basis of sequence similarity. This family groups together a range of proteins, including anr, crp, clp, cysR, fixK, flp, fnr, fnrN, hlyX and ntcA [, ]. Within this family, the HTH motif is situated towards the C terminus.; GO: 0003700 sequence-specific DNA binding transcription factor activity, 0006355 regulation of transcription, DNA-dependent, 0005622 intracellular; PDB: 2OZ6_A 1CGP_B 2GZW_C 1O3T_B 3ROU_A 2CGP_A 3RDI_A 1I5Z_A 3IYD_H 3FWE_B ....
Probab=21.04 E-value=1.2e+02 Score=14.77 Aligned_cols=23 Identities=13% Similarity=0.294 Sum_probs=14.3
Q ss_pred hHHHHHHhcCCCChHHHHHHHHHH
Q 032061 53 TLDQLLSFLKSKSDDQLNTFASEL 76 (148)
Q Consensus 53 T~~el~~~L~~~~~~~~~~~~~~l 76 (148)
|++||.+.||+. .+.+...++.+
T Consensus 4 tr~diA~~lG~t-~ETVSR~l~~l 26 (32)
T PF00325_consen 4 TRQDIADYLGLT-RETVSRILKKL 26 (32)
T ss_dssp -HHHHHHHHTS--HHHHHHHHHHH
T ss_pred CHHHHHHHhCCc-HHHHHHHHHHH
Confidence 788999999986 34455554444
No 47
>KOG1736 consensus Glia maturation factor beta [Extracellular structures]
Probab=20.18 E-value=44 Score=22.11 Aligned_cols=34 Identities=18% Similarity=0.323 Sum_probs=24.6
Q ss_pred EEEccccHHHHHHHHHcCCCCchHH--HHHHhcCCC
Q 032061 31 LVFSPSSIHVLLSLISAGSKGPTLD--QLLSFLKSK 64 (148)
Q Consensus 31 ~v~SP~si~~~L~~l~~ga~g~T~~--el~~~L~~~ 64 (148)
+..||.+...=+.|+|.||...-.+ |+.+++...
T Consensus 91 Iyw~P~~~~~e~~MmYAgak~~~~~~~~~~KvfEir 126 (143)
T KOG1736|consen 91 IYWSPVGCKPEQQMMYAGAKNMLVQTAELTKVFEIR 126 (143)
T ss_pred EEecCccCCHHHHHHHHHHHHHHHHHhhheEEEEec
Confidence 4568999999999999999876554 344455443
No 48
>PRK10188 DNA-binding transcriptional activator SdiA; Provisional
Probab=20.13 E-value=2e+02 Score=20.95 Aligned_cols=37 Identities=11% Similarity=0.181 Sum_probs=26.4
Q ss_pred HHHcCCCCchHHHHHHhcCCCChHHHHHHHHHHHHHHh
Q 032061 44 LISAGSKGPTLDQLLSFLKSKSDDQLNTFASELVAVVF 81 (148)
Q Consensus 44 ~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~ 81 (148)
.|..-|.|.|..||.+.|+++ ...|....+++.+.+.
T Consensus 187 vl~~~a~G~t~~eIa~~l~is-~~TV~~h~~~~~~KL~ 223 (240)
T PRK10188 187 ILKWTAEGKTSAEIAMILSIS-ENTVNFHQKNMQKKFN 223 (240)
T ss_pred HHHHHHcCCCHHHHHHHhCCC-HHHHHHHHHHHHHHhC
Confidence 334447899999999999987 3456666666666553
No 49
>KOG0002 consensus 60s ribosomal protein L39 [Translation, ribosomal structure and biogenesis]
Probab=20.04 E-value=48 Score=17.78 Aligned_cols=14 Identities=7% Similarity=0.406 Sum_probs=11.7
Q ss_pred chhHHHhhcCCccC
Q 032061 134 LSWYTTVIHEGLKF 147 (148)
Q Consensus 134 N~wv~~~T~g~I~~ 147 (148)
=+||.-.|+.+|.|
T Consensus 21 P~WiRm~~gn~iry 34 (48)
T KOG0002|consen 21 PQWIRMRTGNTIRY 34 (48)
T ss_pred cHHHhhccCCccch
Confidence 57999888888876
Done!